Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Active, Not Recruiting

PF-07104091 as a Single Agent and in Combination Therapy

NCT04553133

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +27 more
Locations
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Clive, Iowa, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

NCT06117774

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited Stage Small Cell Lung Cancer, +9 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Santa Monica, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Boca Raton Clinical Research Global South Florida Plantation, Florida, United States
View all 204 locations
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Hospital Universitario Austral Buenos Aires, Argentina
  • Lucen S.A. Buenos Aires, Argentina
  • Consultorio Privado Korbenfeld CABA, Argentina
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
View all 258 locations
View Trial Details
Active, Not Recruiting

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

NCT03703297

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Fort Myers, Florida, United States
View all 183 locations
View Trial Details
Active, Not Recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

NCT04472949

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View all 14 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions